Oncology Infusion Note – Rituximab Cycle 2 Day 1; EBV PCR down-trending (2,000 IU/mL)

ONCOLOGY INFUSION NOTE – RITUXIMAB CYCLE 2 DAY 1; EBV PCR DOWN-TRENDING (2,000 IU/ML)

Encounter 15, Document 1. Patient is a 54-year-old male, status post deceased donor kidney transplant on 1/15/25. 
This note documents transplant and oncology follow-up. 

Interval history, exam, labs, imaging, and pathology reviewed. 
Plan includes adjustment of immunosuppression, infection prophylaxis, DSA monitoring, and coordination with oncology for PTLD management when applicable.
